To determine whether our findings are clinically relevant, we stained glioma tissue sections (n = 50) for BATF2, SDF-1α, HIF-1α (hypoxia marker), CD14 (Mo-MDSCs marker), and CD33 (MDSCs marker). This evidence concerns the gene CXCL12 and central nervous system cancer.